Latest news
Fresenius stock holds steady as earnings and guidance frame the outlook - AD HOC NEWSAD HOC NEWS · Sun, 09 Aug 2026 12:42:21 GMTFresenius receives FDA, EMA acceptance for review of vedolizumab biosimilar candidate - Drug Store NewsDrug Store News · Fri, 07 Aug 2026 14:04:51 GMTFresenius Kabi recalls morphine lot that could lead to death - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 13:29:33 GMTFresenius transitions to registered shares – automatic conversion for shareholders - TradingViewTradingView · Thu, 06 Aug 2026 11:00:04 GMTFresenius Kabi's Vedolizumab Biosimilar Clears FDA and EMA Review Milestone - BioPharma APACBioPharma APAC · Tue, 04 Aug 2026 21:27:58 GMTFutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised - TradingViewTradingView · Tue, 04 Aug 2026 20:03:34 GMTFDA Approves Rituximab Biosimilar Commercialized in US by Fresenius Kabi - Contract PharmaContract Pharma · Tue, 04 Aug 2026 18:43:31 GMTFresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist - Business WireBusiness Wire · Tue, 04 Aug 2026 17:44:00 GMT